Lower riskMedical device recall · FDA · Published December 3, 2025
Medtronic Vanta CP App Software Recall: Risk of Prolonged Surgery
Medtronic recalls specific versions of their Vanta Clinician Programmer software for Samsung tablets due to potential delays in surgical procedures. Affected users should contact Medtronic for details.
Complaints received that Vanta A71200 CP App does not function as intended during use. There is a potential for prolonged or postponed surgical procedure.
Take action
Contact the company
📍Recalling firmMedtronic Neuromodulation7000 Central Ave Ne · Minneapolis, MN 55432-3568
“Medtronic Vanta CP App Software Recall: Risk of Prolonged Surgery.” GovInfoNow, updated August 17, 2026. https://govinfonow.com/recall/50538-medtronic-vanta-cp-app-software-recall-risk-of-prolonged-surgery. Based on FDA recall #Z-1043-2026 (https://api.fda.gov/device/enforcement.json?search=recall_number:%22Z-1043-2026%22&limit=1).
The FDA announced on Dec. 3, 2025, that Medtronic Neuromodulation is recalling A71200 Vanta Clinician Programmer Application (CP App) versions 2.0.2465 and 2.0.2683 because the software may not function as intended during use. This defect poses a potential for prolonged or postponed surgical procedures.
According to the FDA, complaints indicate that the Vanta A71200 CP App does not function as intended during use. This malfunction creates a potential for prolonged or postponed surgical procedures.
Context
GovInfoNow's records show Medtronic Neuromodulation has had 45 other recalls since Aug. 9, 2017. Other recent recalls of similar products include Medtronic SynchroMed Flex Infusion Software Issue (April 8, 2026), Medtronic Restore CP App Model A71100 Software Issue (Nov. 20, 2025), Fresenius Medical Care 5008X CAREsystem Recall (Oct. 25, 2025), Elekta MOSAIQ Oncology System Software Recall (May 21, 2026), and Fresenius Kabi Ivenix Infusion System Software Recall (Nov. 14, 2025).
How to tell if you have this one
Check for software versions 2.0.2465 or 2.0.2683 on Samsung tablets (model CFN CT900). The product number is A71200. Implanted Vanta neurostimulators are not affected by this recall.
Brand
Medtronic
Category
Medical device
Based on the official FDA remedy
What to do — step by step
Check Software Version
Verify your software version on the Samsung tablet by checking the device settings or the software interface.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
Nationwide
Not listed
FDA distribution: “Worldwide - US Nationwide distribution.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA published this recall 49 days after the firm started it.
1Firm started the recall
2FDA classified it Class II
3Published in FDA’s Enforcement Report
Dates from the agency record only; steps without a date are left out.
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
Official source: FDA Recall #Z-1043-2026 (December 3, 2025) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for Z-1043-2026 to see it in context.
Plain-language summary written by qwen3:4b on August 17, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.